Elevated 1-h Post-load Plasma Glucose is Associated with Right Ventricular Morphofunctional Parameters in Hypertensive Patients
Overview
Authors
Affiliations
Purpose: Emerging data demonstrate that type 2 diabetes mellitus (T2DM) is associated with right ventricular (RV) dysfunction. A cutoff point of 155 mg/dL for the 1-hour (h) post-load plasma glucose, during oral glucose tolerance test (OGTT), identifies patients with normal glucose tolerance (NGT) at high risk to develop T2DM and cardiovascular (CV) disease. We investigated if 1-h post-load glucose may affect RV geometry and function in a group of never-treated hypertensive individuals.
Methods: We enrolled 446 Caucasian newly diagnosed hypertensive outpatients. All patients underwent an OGTT and a standard echocardiography. The tricuspid annular plane systolic excursion (TAPSE) and the RV fractional area change (RVFAC) were measured together with systolic pulmonary arterial pressure (s-PAP) and pulmonary vascular resistances (PVR). Insulin sensitivity was evaluated using the Matsuda index.
Results: Among all partecipants, 296 had NGT, 100 impaired glucose tolerance (IGT), and 50 T2DM. Considering the cutoff point of 155 mg/dl for 1-h glucose, NGT subjects were stratified into two groups: NGT < 155 (n = 207), NGT ≥ 155 (n = 89). Subjects NGT ≥ 155 presented a worse metabolic and inflammatory profile than NGT < 155. RV functional parameters (TAPSE, RVFAC, TAPSE/s-PAP, and TAPSE/PVR) were significantly reduced in NGT ≥ 155 subjects compared with NGT < 155 patients. On the contrary, s-PAP and PVR were significantly higher. At multiple regression analysis, 1-h glucose was the strongest predictor of TAPSE in NGT ≥ 155, IGT, and T2DM.
Conclusions: The presence of RV impairment in hypertensive NGT ≥ 155 subjects further complicates their CV burden and it may, at least in part, justify the worse clinical outcome in this setting of patients.
Santilli F, Simeone P Intern Emerg Med. 2024; 19(3):605-607.
PMID: 38512432 DOI: 10.1007/s11739-024-03584-w.
Condoleo V, Maio R, Cassano V, Bonfrate L, Pelaia C, Armentaro G Intern Emerg Med. 2023; 19(1):81-89.
PMID: 37801209 PMC: 10827950. DOI: 10.1007/s11739-023-03442-1.
Cassano V, Pelaia C, Armentaro G, Miceli S, Tallarico V, Perini D Front Endocrinol (Lausanne). 2023; 14:1206336.
PMID: 37484969 PMC: 10361654. DOI: 10.3389/fendo.2023.1206336.
Clinical Usefulness of Right Ventricle-Pulmonary Artery Coupling in Cardiovascular Disease.
He Q, Lin Y, Zhu Y, Gao L, Ji M, Zhang L J Clin Med. 2023; 12(7).
PMID: 37048609 PMC: 10095537. DOI: 10.3390/jcm12072526.
Condoleo V, Bonfrate L, Armentaro G, Pelaia C, Cassano V, De Marco M Intern Emerg Med. 2023; 18(3):769-779.
PMID: 36808594 DOI: 10.1007/s11739-023-03220-z.